In This Section

ASPET-CNPHARS Joint Symposium: Parkinson’s and Alzheimer Diseases: Neuronal Mechanism and Therapeutic Discoveries to Combat Neurodegenerative Diseases

Sunday April 07, 2019

3:00 pm - 5:00 pm Eastern Time (ET)

Room W206 A


Chair :

Habibeh Khoshbouei
Univ of Florida

Yongxiang Zhang
Beijing Institute of Pharmacology and Toxicology

Sponsored by the Chinese Pharmacological Society (CNPHARS)

Neurodegeneration is a feature of devastating diseases such as Parkinson’s disease and Alzheimer disease. There is an urgent need to develop effective treatments and develop relevant model systems to shed light on the mechanisms underlying neurodegenerative diseases. This symposium highlights the latest advances made in understanding neuronal mechanisms of neurodegenerative diseases, diagnostic approaches and the latest pharmacological approaches including traditional Chinese medicine. Human clinical studies presented in this symposium will describe current clinical and experimental approaches to treat Parkinson’s disease and how to improve quality of life in patients with neurodegenerative diseases. This symposium is co-sponsored by the Chinese Pharmacological Society and American Society for Pharmacology & Experimental Therapeutics.



Guanhua Du - Institute of Materia Medica, Chinese Academy of Medical Sciences

The Mechanism of Baicalein Inhibits Tremor and Other Symptoms in Parkinson’s Disease Animal Models

Mike Beckstead - Oklahoma Medical Research Foundation, Oklahoma City

Impaired Dopamine Neuron Physiology Precedes Disruption of Somatodendritic Morphology in a Progressive Mouse Model of Parkinson’s

Wenxia Zhou - Beijing Institute of Pharmacology and Toxicology

Network Based Pharmacological Actions and Mechanisms of TCM Prescription Liuwei Dihuang Decocotion and its New Formula LW-AFC on the Experimental Therapy of Alzheimer's Disease

Randy Blakely - FAU Brain Institute

A Novel Mechanism Required for Glial Support of DA Neuron Survival Revealed via C.elegans Forward Genetics